ALCON INCALCEarnings & Financial Report
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Revenue
$2.5B
Gross Profit
$1.4B
Operating Profit
$318.0M
Net Profit
$223.0M
Gross Margin
55.0%
Operating Margin
12.7%
Net Margin
8.9%
YoY Growth
3.1%
EPS
$0.45
ALCON INC Q2 FY2024 Financial Summary
ALCON INC reported revenue of $2.5B (up 3.1% YoY) for Q2 FY2024, with a net profit of $223.0M (up 32.0% YoY) (8.9% margin). Cost of goods sold was $1.1B, operating expenses totaled $1.1B.
Key Financial Metrics
| Total Revenue | $2.5B |
|---|---|
| Net Profit | $223.0M |
| Gross Margin | 55.0% |
| Operating Margin | 12.7% |
| Report Period | Q2 FY2024 |
ALCON INC Quarterly Revenue & Net Profit History
ALCON INC results over the last 4 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2025 | $2.6B | +4.0% | $176.0M | 6.8% |
| Q2 FY2024 | $2.5B | +3.1% | $223.0M | 8.9% |
| Q2 FY2023 | $2.4B | +9.2% | $169.0M | 7.0% |
| Q2 FY2022 | $2.2B | +5.1% | $148.0M | 6.7% |
Income Statement
| Q2 2022 | Q2 2023 | Q2 2024 | Q2 2025 | |
|---|---|---|---|---|
| Revenue | $2.22B | $2.42B | $2.50B | $2.60B |
| YoY Growth | 5.1% | 9.2% | 3.1% | 4.0% |
Balance Sheet
| Q2 2022 | Q2 2023 | Q2 2024 | Q2 2025 | |
|---|---|---|---|---|
| Assets | $27.73B | $29.21B | $29.72B | $31.39B |
| Liabilities | $8.19B | $9.27B | $8.78B | $9.26B |
| Equity | $19.54B | $19.94B | $20.94B | $22.13B |